Information:
Fel:
ID
12873
Beskrivning
EnligHTN German Observational Study; ODM derived from: https://clinicaltrials.gov/show/NCT01996033
Länk
https://clinicaltrials.gov/show/NCT01996033
Nyckelord
Versioner (1)
- 2016-01-04 2016-01-04 -
Uppladdad den
4 januari 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Uncontrolled Hypertension NCT01996033
Eligibility Uncontrolled Hypertension NCT01996033
- StudyEvent: Eligibility
Similar models
Eligibility Uncontrolled Hypertension NCT01996033
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
denervation renal
Item
subject is planned to undergo a renal denervation procedure for the treatment of hypertension
boolean
C0011307 (UMLS CUI [1,1])
C0022646 (UMLS CUI [1,2])
C0022646 (UMLS CUI [1,2])
age
Item
subject is ≥18 years of age at time of consent
boolean
C0001779 (UMLS CUI [1])
informed consent
Item
subject must be able and willing to provide written informed consent
boolean
C0021430 (UMLS CUI [1])
compliance behavior
Item
subject must be able and willing to comply with the required follow-up schedule
boolean
C1321605 (UMLS CUI [1])
systolic blood pressure
Item
subject has office systolic blood pressure (sbp) ≥ 140 mmhg
boolean
C0871470 (UMLS CUI [1])
hypertension; anti-hypertensive medications
Item
subject has established hypertension (diagnosed ≥12 months prior to baseline) and is on a guideline based drug regimen at a stable (≥ 14 days) and a fully tolerated dose consisting of ≥3 anti-hypertensive medications (including 1 diuretic), or subject has documented drug intolerance to 2 or more of the 4 major classes of anti-hypertensives (ace-i/ angiotensin receptor blocker (arb), calcium channel blockers, beta blockers, or diuretic) and is unable to take 3 anti-hypertensive drugs
boolean
C0020538 (UMLS CUI [1])
C0003364 (UMLS CUI [2])
C0003364 (UMLS CUI [2])
renal artery stenosis
Item
subject has known significant renovascular abnormalities such as renal artery stenosis > 30%
boolean
C0035067 (UMLS CUI [1])
renal angioplasty; renal stents
Item
subject has undergone prior renal angioplasty, renal denervation, indwelling renal stents, and/or abdominal aortic stent grafts
boolean
C1282893 (UMLS CUI [1])
C1262325 (UMLS CUI [2])
C1262325 (UMLS CUI [2])
valvular heart disease
Item
subject has a history of hemodynamically significant valvular heart disease
boolean
C0018824 (UMLS CUI [1])
coagulopathy
Item
subject has blood clotting abnormalities
boolean
C0005779 (UMLS CUI [1])
life expectancy
Item
subject life expectancy is < 12 months, as determined by the study investigator
boolean
C0023671 (UMLS CUI [1])
Study Subject Participation Status
Item
subject is participating in another clinical study which has the potential
boolean
C2348568 (UMLS CUI [1])